President Trump’s job approval rating has rebounded after a second-term low, according to new polling averages from Decision Desk HQ (DDHQ). The president’s approval rating in the DDHQ average of ...

Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

Anyone who uses AI systems knows the frustration: a prompt is given, the response misses the mark, and the cycle repeats. This trial-and-error loop can feel ...

In the third and fourth paragraphs of the release all dates should be for January of 2026 (instead of January of 2025). First Trust Advisors L.P. (“FTA”) announced today approval of the liquidation of ...

WASHINGTON, Dec 9 (Reuters) - President Donald Trump's approval rating edged up to 41% in the past week as Republicans warmed to his handling of the cost of living, a sign the administration's new ...

President Donald Trump's approval ratings continue dipping in most polls as he wrapped up this week juggling major legal, diplomatic and political developments. On Friday, the Supreme Court agreed to ...

The shift, while small, is notable after months of stability in President Trump’s approval rating. Note: Data as of 5 p.m. Eastern time on Dec. 4. The New York Times By Ruth Igielnik and Tyler Pager ...

JAMES CITY — The James City County Planning Commission heard proposals Wednesday evening that could bring major changes to the county’s central corridor. Commission members recommended approval of ...

President Trump acknowledged his approval ratings have slipped. Recent polling data from multiple aggregators show Trump's approval rating has dropped to a new low in recent weeks. According to a ...

Microsoft has been adding AI features to Windows 11 for years, but things have recently entered a new phase, with both generative and so-called “agentic” AI features working their way deeper into the ...

For the first time, patients with abnormal cells detected in their bone marrow have a treatment option before the condition develops into multiple myeloma. The FDA has approved Johnson & Johnson’s ...

President Trump’s approval hit a record low for his second term in the latest CNN/SSRS survey released Monday. The poll, conducted in late October, shows 37 percent of surveyed Americans approved of ...